FDCGX | VCSAX | FDCGX / VCSAX | |
Total Expense Ratio | 1.72 | 0.09 | 1,911% |
Annual Report Gross Expense Ratio | 1.72 | 0.09 | 1,911% |
Fund Existence | 19 years | 22 years | - |
Gain YTD | 0.908 | 5.334 | 17% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 100000 | - |
Min. Initial Investment IRA | 500 | N/A | - |
Net Assets | 1.14B | 8.78B | 13% |
Annual Yield % from dividends | 0.92 | 2.28 | 40% |
Returns for 1 year | -7.85 | 3.51 | -224% |
Returns for 3 years | -0.44 | 16.62 | -3% |
Returns for 5 years | 4.77 | 35.33 | 13% |
Returns for 10 years | 3.72 | 79.76 | 5% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIS | 14.58 | 0.53 | +3.74% |
ProShares UltraShort Nasdaq Biotech | |||
PSH | 50.81 | -0.01 | -0.02% |
PGIM Short Duration High Yield ETF | |||
PAUG | 41.70 | -0.05 | -0.12% |
Innovator U.S. Equity Power BufferETFAug | |||
SPBW | 26.54 | -0.04 | -0.16% |
AllianzIM Buffer20 Allocation ETF | |||
HYFI | 37.63 | -0.07 | -0.20% |
AB High Yield ETF |